ArticleScientific reports2026
A memory-driven pneumonia dynamics model validated against Ethiopian mortality data: a fractional-order differential equation framework.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Every year, pneumonia kills millions across the globe, disproportionately claiming the lives of children under five and immunocompromised adults in low-resource settings, yet the mathematical tools deployed to understand and contain it remain fundamentally inadequate. Classical integer-order epidemic models assume that disease dynamics depend solely on the present state of a system, a biologically untenable assumption for pneumonia, where cumulative immune history, pathogen exposure memory, and treatment delays collectively govern transmission trajectories. This study deviates from that tradition by introducing a well-stablished Caputo fractional-order SEIHR model including hereditary effects and epidemiological memory as part of the mathematical framework governing the disease progression. Biological validity is guaranteed through comprehensive well-posedness analysis, with solution positivity and boundedness established via fractional comparison theorems and Mittag -Leffler function theory within a positively invariant feasible region. In this work, the basic reproduction number [Formula: see text] is calculated by the next-generation matrix method and, by employing the fractional linearization theory and Lyapunov functional construction, both the local and global asymptotic stability of the disease-free equilibrium and the endemic equilibrium are formally proved, which are the first complete stability proofs ever obtained for a fractional-order pneumonia mode. A landmark theoretical finding reveals that the fractional-order parameter α operates as a precise memory-strength regulator, whereby lower values generate slower convergence trajectories and prolonged infectious periods that far more faithfully capture the biological reality of pneumonia than any integer-order model achieves. Sensitivity analysis demonstrates that parameters β and Λ should be targeted for intervention first since they are most crucial. On the other hand, by carrying out bifurcation analysis, we could observe that there is a threshold that divides the system between elimination and endemicity, namely [Formula: see text]=1. The proposed model yields a good fitting to the WHO pneumonia mortality in Ethiopia for 2018-2020, with an [Formula: see text] of 0.995 and maximum relative error below 0.55%. The conclusions drawn are obvious and decisive: memory effect is neither an artistic detail, nor a mathematically luxury, but an indispensable element of epidemic modeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.